Back
Cullinan Therapeutics Stock Price Chart
Sell
38
CGEM
Cullinan Therapeutics
Last Price:
23.17
Seasonality Move:
13.25%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bearish and CGEM is experiencing slight selling pressure.
Cullinan Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.96 | Sell |
20-day SMA: | 24.97 | Sell |
50-day SMA: | 20.06 | Buy |
200-day SMA: | 13.4 | Buy |
8-day EMA: | 25.4 | Sell |
20-day EMA: | 24.51 | Sell |
50-day EMA: | 21.34 | Buy |
200-day EMA: | 15.41 | Buy |
Cullinan Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.65 | Buy |
Relative Strength Index (14 RSI): | 48.11 | Sell |
Chaikin Money Flow: | -368240 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.61 - 28.17) | Sell |
Bollinger Bands (100): | (12.43 - 22.33) | Buy |
Cullinan Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cullinan Therapeutics Stock
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 23.17 while CGEM 8-day simple moving average is 25.96, which is a Sell signal.
- The stock price of CGEM is 23.17 while Cullinan Therapeutics 20-day SMA is 24.97, which makes it a Sell.
- Cullinan Therapeutics 50-day simple moving average is 20.06 while CGEM share price is 23.17, making it a Buy technically.
- CGEM stock price is 23.17 and Cullinan Therapeutics 200-day simple moving average is 13.40, creating a Buy signal.
CGEM Technical Analysis vs Fundamental Analysis
Sell
38
Cullinan Therapeutics (CGEM)
is a Sell
Is Cullinan Therapeutics a Buy or a Sell?
-
Cullinan Therapeutics stock is rated a Sell
The current Cullinan Therapeutics [CGEM] share price is $23.17. The Score for CGEM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Cullinan Therapeutics Stock Info
Market Cap:
1.34B
Price in USD:
23.17
Share Volume:
826.49K
Cullinan Therapeutics 52-Week Range
52-Week High:
30.19
52-Week Low:
7.64
Sell
38
Cullinan Therapeutics (CGEM)
is a Sell
Cullinan Therapeutics Share Price Forecast
-
What is the Cullinan Therapeutics stock price today?
The Cullinan Therapeutics stock price is 23.17 USD today. -
Will CGEM stock go up or go down?
Cullinan Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cullinan Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cullinan Therapeutics is overvalued.
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 23.17 while CGEM 8-day exponential moving average is 25.40, which is a Sell signal.
- The stock price of CGEM is 23.17 while Cullinan Therapeutics 20-day EMA is 24.51, which makes it a Sell.
- Cullinan Therapeutics 50-day exponential moving average is 21.34 while CGEM share price is 23.17, making it a Buy technically.
- CGEM stock price is 23.17 and Cullinan Therapeutics 200-day simple moving average is 15.41, creating a Buy signal.
Fundamental Analysis of Cullinan Therapeutics
Is Cullinan Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.12 per share, an increase this year of $0.88 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Cullinan Therapeutics
Should I short Cullinan Therapeutics stock?
- CGEM Moving Average Covergence Divergence (MACD) indicator is 1.65, suggesting Cullinan Therapeutics is a Buy
- Cullinan Therapeutics Relative Strength Index (RSI) is 48.11, which suggest Cullinan Therapeutics is oversold
- The Bollinger Bands (25) for Cullinan Therapeutics is (18.61 - 28.17), which suggest Cullinan Therapeutics is a Buy
- The Bollinger Bands (100) for Cullinan Therapeutics is (12.43 - 22.33), which suggest Cullinan Therapeutics is a Buy
* Cullinan Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.